Evaluating the performance of high-sensitivity troponin-T in the emergency department during the COVID-19 pandemic
BMJ Evid Based Med
.
2022 Apr;27(2):129-130.
doi: 10.1136/bmjebm-2020-111534.
Epub 2020 Sep 23.
Authors
Ali A Alsaad
1
,
Ernest Wang
2
,
Hong Lee
3
,
Mark Lampert
4
,
Philip Krause
4
,
Carl Tommaso
4
,
Gregory Mishkel
4
,
John Erwin
4
,
Christopher Boyle
5
,
Sarah Donlan
2
,
Jeremy Smiley
2
,
Mahalakshmi Halasyamani
5
Affiliations
1
Cardiology, NorthShore University HealthSystem, Evanston, Illinois, USA alsaad2018@gmail.com.
2
Emergency Medicine, NorthShore University HealthSystem, Evasnton, Illinois, USA.
3
Labratory Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA.
4
Cardiology, NorthShore University HealthSystem, Evanston, Illinois, USA.
5
Quality and Transformation, NorthShoreUniversity HealthSystem, Evanston, Illinois, USA.
PMID:
32967891
DOI:
10.1136/bmjebm-2020-111534
No abstract available
Keywords:
coronary heart disease; emergency medicine.
Publication types
Letter
MeSH terms
COVID-19*
Emergency Service, Hospital
Humans
Pandemics
Troponin T*
Substances
Troponin T